[1] |
HU Biyuan, WANG Jing, ZHENG Weiqi, HU Hongping, CHEN Yongwu.
Suicidal tendency and paresthesia induced by voriconazole: a case report
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 469-472.
|
[2] |
ZHONG Yingying, WANG Zhao, ZUO Tiantian, LI Yaolei, LI Hailiang, MA Shuangcheng.
Research progress on detection and risk assessment of exogenous heavy metals and related elements in Codonopsis Radix
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1309-1315.
|
[3] |
JIANG Hao, ZHANG Bing, ZHANG Xiaomeng, LIN Zhijian, LYU Jintao, ZHANG Dan.
Descriptions of pharmacovigilance in materia medica works of Sui, Tang and the Five Dynasties
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 987-993.
|
[4] |
YANG Miao, YANG Li, ZHAO Zhigang.
Current applications and rationality of ribavirin in pediatrics in seven cities in China
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(4): 408-412.
|
[5] |
LI Lan, KONG Fanyao, ZHU Ying, SHEN Lu.
Developments and Suggestions on Cosmetics Adverse Reaction Monitoring in China
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(9): 850-854.
|
[6] |
SHI Lin, LIU Xin, ZHANG Bing.
Study on Prevention of Drug Toxicity in Pharmacovigilance Thought of the Compendium of Materia Medica
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(7): 404-410.
|
[7] |
SHI Lin, LIU Xin, ZHANG Bing.
Study on Use of Drug Toxicity in Pharmacovigilance Thought of the Compendium of Materia Medica
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(7): 399-403.
|
[8] |
SHI Lin, LIU Xin, ZHANG Bing.
Study on Recognition of Drug Toxicity in Pharmacovigilance Thought of the Compendium of Materia Medica
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(6): 347-351.
|
[9] |
WAN Kaihua, WEI Yu, XU Yuming, ZHOU Juan.
Current Status of Drug Abuse Epidemic and Intervention Research in China
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(6): 338-341.
|
[10] |
LI Jianguo, QIN Xiujun, HU Bo, GAO Jie, LI Mei, LIU Huan, AN Quan, JIN Hongtao.
Research Status and Prospect of Radiopharmaceuticals
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(1): 27-31.
|
[11] |
CAO Lujuan, LI Xinling, TIAN Chunhua, LIU Cuili, ZHAO Xia.
Current Status and Thinking of MAH on Post-marketing Adverse Drug Reaction Report of China
[J]. Chinese Journal of Pharmacovigilance, 2018, 15(11): 658-662.
|
[12] |
ZHAO Xia, LENG Meiling, WANG Peng, LI Xinling, CAO Lujuan, TIAN Chunhua, LIU Cuili.
Research on Current Status and Countermeasures of Information Collection on Adverse Drug Reactions by Drug Manufacturers from Medical Institutions in China
[J]. Chinese Journal of Pharmacovigilance, 2018, 15(11): 652-657.
|
[13] |
CHU Yan-qi, WANG Zhi-zhou, SHEN Jiang-hua, ZHANG Miao, ZHANG Qing-xia, ZENG Yan, YAN Su-ying.
Evaluation on Status of Therapeutic Drug Monitoring of Vancomycinin in Our Hospital Based on Therapeutic Drug Monitoring of Vancomycin of China
[J]. Chinese Journal of Pharmacovigilance, 2017, 14(7): 435-438.
|
[14] |
WANG Zhi-ying, JIAO Can-wu.
Analysis of Infusion Solutions Clinical Application Status in Our Hospital
[J]. Chinese Journal of Pharmacovigilance, 2014, 11(6): 373-376.
|
[15] |
YUAN Xing-dong GAO Jing ZHOU Juan ZHONG Chang-ming REN Jing-tian.
The Status and Prospective of PSUR in China
[J]. Chinese Journal of Pharmacovigilance, 2014, 11(6): 333-335.
|